• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症突变特征对人类基因组转录因子基序的影响。

Impact of cancer mutational signatures on transcription factor motifs in the human genome.

机构信息

Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.

Faculty of Biosciences, Heidelberg University, Heidelberg, 69120, Germany.

出版信息

BMC Med Genomics. 2019 May 20;12(1):64. doi: 10.1186/s12920-019-0525-4.

DOI:10.1186/s12920-019-0525-4
PMID:31109337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6528224/
Abstract

BACKGROUND

Somatic mutations in cancer genomes occur through a variety of molecular mechanisms, which contribute to different mutational patterns. To summarize these, mutational signatures have been defined using a large number of cancer genomes, and related to distinct mutagenic processes. Each cancer genome can be compared to this reference dataset and its exposure to one or the other signature be determined. Given the very different mutational patterns of these signatures, we anticipate that they will have distinct impact on genomic elements, in particular motifs for transcription factor binding sites (TFBS).

METHODS

We used the 30 mutational signatures from the COSMIC database, and derived a theoretical framework to infer the impact of these signatures on the alteration of transcription factor (TF) binding motifs from the JASPAR database. Hence, we translated the trinucleotide mutation frequencies of the signatures into alteration frequencies of specific TF binding motifs, leading either to creation or disruption of these motifs.

RESULTS

Motif families show different susceptibility to alterations induced by the mutational signatures. For certain motifs, a high correlation is observed between the TFBS motif creation and disruption events related to the information content of the motif. Moreover, we observe striking patterns regarding for example the Ets-motif family, for which a high impact of UV induced signatures is observed. Our model also confirms the susceptibility of specific transcription factor motifs to deamination processes.

CONCLUSION

Our results show that the mutational signatures have different impact on the binding motifs of transcription factors and that for certain high complexity motifs there is a strong correlation between creation and disruption, related to the information content of the motif. This study represents a background estimation of the alterations due purely to mutational signatures in the absence of additional contributions, e.g. from evolutionary processes.

摘要

背景

癌症基因组中的体细胞突变是通过多种分子机制发生的,这些机制导致了不同的突变模式。为了总结这些突变模式,已经使用大量的癌症基因组定义了突变特征,并将其与不同的诱变过程相关联。每个癌症基因组都可以与这个参考数据集进行比较,并确定其对一个或另一个特征的暴露程度。鉴于这些特征的突变模式非常不同,我们预计它们将对基因组元件产生不同的影响,特别是转录因子结合位点(TFBS)的基序。

方法

我们使用了 COSMIC 数据库中的 30 个突变特征,并推导了一个理论框架,从 JASPAR 数据库推断这些特征对转录因子(TF)结合基序改变的影响。因此,我们将特征的三核苷酸突变频率转化为特定 TF 结合基序改变的频率,导致这些基序的产生或破坏。

结果

基序家族对突变特征诱导的改变表现出不同的易感性。对于某些基序,与基序信息含量相关的 TFBS 基序产生和破坏事件之间存在高度相关性。此外,我们观察到了一些引人注目的模式,例如 Ets 基序家族,其中观察到 UV 诱导特征的高影响。我们的模型还证实了特定转录因子基序对脱氨酶过程的易感性。

结论

我们的结果表明,突变特征对转录因子结合基序的影响不同,对于某些高复杂度基序,产生和破坏之间存在很强的相关性,与基序的信息含量有关。这项研究代表了在没有额外贡献(例如进化过程)的情况下,由于突变特征而导致的改变的背景估计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/7beb6393ffb6/12920_2019_525_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/bf84c5fba860/12920_2019_525_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/09818f4c5655/12920_2019_525_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/64f29c268e6f/12920_2019_525_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/4a6fb1255d4b/12920_2019_525_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/f249db32c37b/12920_2019_525_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/66d479cbcdd7/12920_2019_525_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/95dab854b908/12920_2019_525_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/7beb6393ffb6/12920_2019_525_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/bf84c5fba860/12920_2019_525_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/09818f4c5655/12920_2019_525_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/64f29c268e6f/12920_2019_525_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/4a6fb1255d4b/12920_2019_525_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/f249db32c37b/12920_2019_525_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/66d479cbcdd7/12920_2019_525_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/95dab854b908/12920_2019_525_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78de/6528224/7beb6393ffb6/12920_2019_525_Fig8_HTML.jpg

相似文献

1
Impact of cancer mutational signatures on transcription factor motifs in the human genome.癌症突变特征对人类基因组转录因子基序的影响。
BMC Med Genomics. 2019 May 20;12(1):64. doi: 10.1186/s12920-019-0525-4.
2
Topography of mutational signatures in human cancer.人类癌症中突变特征的地形。
Cell Rep. 2023 Aug 29;42(8):112930. doi: 10.1016/j.celrep.2023.112930. Epub 2023 Aug 4.
3
Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.秀丽隐杆线虫突变特征分析:对癌症基因组分析的启示。
DNA Repair (Amst). 2020 Nov;95:102957. doi: 10.1016/j.dnarep.2020.102957. Epub 2020 Aug 28.
4
Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes.癌症基因组调控元件突变率可变性的功能和遗传决定因素。
Genome Biol. 2021 May 3;22(1):133. doi: 10.1186/s13059-021-02318-x.
5
Genome Sequencing and RNA-Motif Analysis Reveal Novel Damaging Noncoding Mutations in Human Tumors.基因组测序和 RNA 基序分析揭示人类肿瘤中的新型致病变异。
Mol Cancer Res. 2018 Jul;16(7):1112-1124. doi: 10.1158/1541-7786.MCR-17-0601. Epub 2018 Mar 28.
6
The shaping of cancer genomes with the regional impact of mutation processes.癌症基因组的形成与突变过程的区域影响。
Exp Mol Med. 2022 Jul;54(7):1049-1060. doi: 10.1038/s12276-022-00808-x. Epub 2022 Jul 28.
7
Mutational processes in cancer preferentially affect binding of particular transcription factors.癌症中的突变过程优先影响特定转录因子的结合。
Sci Rep. 2021 Feb 8;11(1):3339. doi: 10.1038/s41598-021-82910-0.
8
The repertoire of mutational signatures in human cancer.人类癌症中的突变特征谱。
Nature. 2020 Feb;578(7793):94-101. doi: 10.1038/s41586-020-1943-3. Epub 2020 Feb 5.
9
Pan-cancer analysis of somatic mutations and epigenetic alterations in insulated neighbourhood boundaries.全景癌症分析体细胞突变和绝缘邻域边界的表观遗传改变。
PLoS One. 2020 Jan 16;15(1):e0227180. doi: 10.1371/journal.pone.0227180. eCollection 2020.
10
Mutational signatures and mutable motifs in cancer genomes.癌症基因组中的突变特征和可突变基序。
Brief Bioinform. 2018 Nov 27;19(6):1085-1101. doi: 10.1093/bib/bbx049.

引用本文的文献

1
Mutational Signatures: From Methods to Mechanisms.突变特征:从方法到机制。
Annu Rev Biomed Data Sci. 2021 Jul 20;4:189-206. doi: 10.1146/annurev-biodatasci-122320-120920. Epub 2021 May 11.
2
MutViz 2.0: visual analysis of somatic mutations and the impact of mutational signatures on selected genomic regions.MutViz 2.0:体细胞突变的可视化分析以及突变特征对选定基因组区域的影响。
NAR Cancer. 2021 Apr 9;3(2):zcab012. doi: 10.1093/narcan/zcab012. eCollection 2021 Jun.
3
Mutational processes in cancer preferentially affect binding of particular transcription factors.

本文引用的文献

1
ETS transcription factors induce a unique UV damage signature that drives recurrent mutagenesis in melanoma.ETS 转录因子诱导独特的 UV 损伤特征,从而驱动黑色素瘤的反复突变。
Nat Commun. 2018 Jul 6;9(1):2626. doi: 10.1038/s41467-018-05064-0.
2
Recurrent and functional regulatory mutations in breast cancer.乳腺癌中的复发性和功能性调控突变。
Nature. 2017 Jul 6;547(7661):55-60. doi: 10.1038/nature22992. Epub 2017 Jun 28.
3
APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL.载脂蛋白B mRNA编辑酶催化多肽样蛋白(APOBEC)特征性突变产生一种致癌增强子,该增强子驱动T细胞急性淋巴细胞白血病(T-ALL)中LMO1的表达。
癌症中的突变过程优先影响特定转录因子的结合。
Sci Rep. 2021 Feb 8;11(1):3339. doi: 10.1038/s41598-021-82910-0.
4
Prediction of genome-wide effects of single nucleotide variants on transcription factor binding.预测单核苷酸变异对转录因子结合的全基因组影响。
Sci Rep. 2020 Oct 19;10(1):17632. doi: 10.1038/s41598-020-74793-4.
5
Systems biology approaches integrated with artificial intelligence for optimized metabolic engineering.将系统生物学方法与人工智能相结合以实现优化的代谢工程。
Metab Eng Commun. 2020 Dec;11:e00149. doi: 10.1016/j.mec.2020.e00149. Epub 2020 Oct 9.
6
Mutation bias interacts with composition bias to influence adaptive evolution.突变偏向与组成偏向相互作用影响适应性进化。
PLoS Comput Biol. 2020 Sep 28;16(9):e1008296. doi: 10.1371/journal.pcbi.1008296. eCollection 2020 Sep.
7
Passenger Mutations in More Than 2,500 Cancer Genomes: Overall Molecular Functional Impact and Consequences.超过 2500 个癌症基因组中的乘客突变:整体分子功能影响和后果。
Cell. 2020 Mar 5;180(5):915-927.e16. doi: 10.1016/j.cell.2020.01.032. Epub 2020 Feb 20.
Leukemia. 2017 Oct;31(10):2057-2064. doi: 10.1038/leu.2017.75. Epub 2017 Mar 6.
4
Nucleotide excision repair is impaired by binding of transcription factors to DNA.核苷酸切除修复会因转录因子与 DNA 的结合而受损。
Nature. 2016 Apr 14;532(7598):264-7. doi: 10.1038/nature17661.
5
Exploring the implications of distinct mutational signatures and mutation rates in aging and cancer.探索不同突变特征和突变率在衰老与癌症中的意义。
Genome Med. 2016 Mar 17;8(1):30. doi: 10.1186/s13073-016-0286-z.
6
JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles.JASPAR 2016:转录因子结合谱开放获取数据库的重大扩展与更新
Nucleic Acids Res. 2016 Jan 4;44(D1):D110-5. doi: 10.1093/nar/gkv1176. Epub 2015 Nov 3.
7
Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.癌基因调控。通过非编码基因间元件的体细胞突变形成的致癌超级增强子。
Science. 2014 Dec 12;346(6215):1373-7. doi: 10.1126/science.1259037. Epub 2014 Nov 13.
8
Signatures of mutational processes in human cancer.人类癌症中的突变过程特征。
Nature. 2013 Aug 22;500(7463):415-21. doi: 10.1038/nature12477. Epub 2013 Aug 14.
9
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.TERT 启动子突变在神经胶质瘤和一小部分源自自我更新率低的细胞的肿瘤中频繁发生。
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6021-6. doi: 10.1073/pnas.1303607110. Epub 2013 Mar 25.
10
Impact of deleterious passenger mutations on cancer progression.有害乘客突变对癌症进展的影响。
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2910-5. doi: 10.1073/pnas.1213968110. Epub 2013 Feb 6.